
Piero Santantonio
entrepreneurMale0.0Global Dominance: 0.00%
Piero Santantonio is the founder of Mitocon, an organization focused on supporting individuals with mitochondrial diseases. He is actively involved in advocating for legislative changes in Italy to allow mitochondrial DNA replacement therapies. Santantonio's work aims to make innovative reproductive technologies available to families affected by mitochondrial mutations, highlighting the need for progress in medical options for those at risk of transmitting serious genetic conditions.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Piero Santantonio is the founder of Mitocon and is working on legislation to allow mitochondrial replacement therapy in Italy.
In Inghilterra, grazie al trasferimento pronucleare, sono nati 8 bambini sani da mamme con mutazioni del DNA mitocondrialeCorriere della Sera·
Italy· 2025-07-17


